Locations:
Search IconSearch

Is Mitral Valve Repair a Specialty?

Surgeon volume matters, so let’s start acting like it

Jeff Loerch mitral valve repair illustration

Is mitral valve repair a specialty? Yes, contend three Cleveland Clinic cardiothoracic surgeons in a recent editorial in the Journal of the American College of Cardiology (JACC).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“The ‘jack of all trades’ cardiac surgeon represents an outmoded, unattainable ideal,” write the editorialists — A. Marc Gillinov, MD; Stephanie Mick, MD; and Rakesh Suri, MD, DPhil. “Excellence requires specialization,” they continue, noting that “[t]oday, trainees often choose to focus on particular areas within cardiac surgery: these include thoracic aortic disease, heart failure, congenital heart surgery, and transcatheter aortic valve replacement. Practicing surgeons should do the same…[and] mitral valve repair should be added to this list of specialties.”

Fueled by a new data analysis

Their editorial comes in the wake of an analysis of a mandatory New York State database published in JACC showing that cardiac surgeons who perform fewer than 25 mitral valve operations a year were significantly more likely to replace, rather than repair, mitral valves in patients with degenerative disease than were their counterparts who do 25 or more mitral valve surgeries a year. Patients of the lower-volume surgeons also had significantly worse survival and significantly higher reoperation rates compared with patients of high-volume surgeons.

The analysis focused on mitral valve repair rates because repair is established as conferring superior outcomes in degenerative mitral valve disease compared with replacement. The investigators, from the Icahn School of Medicine at Mount Sinai and Stony Brook University Hospital, found that operators with 10 or fewer mitral valve cases annually had a mean repair rate of 48 percent while those with more than 50 cases annually had a mean repair rate of 77 percent (P < .001).

Advertisement

The Cleveland Clinic editorialists note that “no examination of this topic has ever found…that surgeons’ volume or experience fails to influence repair rates and results. The weight of these data strongly supports the notion that valve repair for degenerative disease is a specialty.”

Two more key questions

The editorialists go on to observe that this conclusion gives rise to two related questions of great import to patients and providers alike:

  1. Which surgeons should operate on patients with degenerative mitral valve disease? Acknowledging that the answer to this question can seem self-serving, the editorialists (all of whom are mitral valve repair specialists) point out that the primary consideration must be improved patient care, regardless of perceptions. They add that there is no barrier to surgeons who desire to develop expertise in mitral valve repair, and that this can be done via numerous opportunities to study with expert mitral valve surgeons around the nation and the world. Once a surgeon has developed mitral valve expertise, they recommend a minimum volume of 25 mitral operations a year (averaged over a three-year period) as “a good threshold” for maintaining and further developing expertise.
  2. Does the hospital matter? Yes, according to the editorialists. “In addition to a focused surgeon, the hospital must have cardiologists interested in mitral valve disease and state-of-the-art intraoperative 2- and 3-dimensional transesophageal echocardiography,” they write. They support this conclusion by noting that the new JACC study of the New York State database found that “lower-volume surgeons who operate in the same institution as higher-volume surgeons benefit from this situation and achieve higher repair rates than do surgeons operating in other institutions.”

Advertisement

Bottom line: Volume matters

The Cleveland Clinic editorialists concede that while their recommendation for overt specialization in mitral valve repair will generate controversy, it is fundamentally a data-driven position. “Surgeon volume matters,” they conclude.

Read the full editorial by Drs. Gillinov, Mick and Suri here.

Advertisement

Related Articles

side-by-side heart scans with color markings

ICE-Guided Anatomic Approach to Cardioneuroablation Abolishes Vasovagal Syncope Recurrences

Intracardiac echo mapping of para-septal fat pads provides fast, accurate and radiation-free targeting

illustrated robot arms tying a suture over a heart valve during an operation

New CME Offering Aims to Advance and Enhance Robotic Cardiac and Thoracic Surgery

Join us in Cleveland July 17 for a practical, first-of-kind course

bulging aorta in stylized illustration of female adult body

New Data Suggest GLP-1 Receptor Agonists Slow Abdominal Aortic Aneurysm Progression

Robust signal from observational study raises prospect of a long-sought medical therapy

exposed heart valve during open heart surgery, with podcast button overlay

Aortic Valve Repair for Aortic Regurgitation (Podcast)

Expert advice on repair vs. replacement, timing of surgery in asymptomatic cases and much more

Woman getting her blood pressure checked by a physician

Tonlamarsen Lowers Angiotensinogen in Patients With Uncontrolled Hypertension

Blood pressure decreases equally in study groups receiving monthly or one-time doses

stylized scientific illustration of hormone receptors

Dual-Agonist Incretin Therapy Outshines GLP-1 Agonist in Broad Cardiorenal Outcomes

Post hoc analysis of SURPASS-CVOT trial has implications for future cardiovascular outcome trials

gene sequence display with superimposed EKG tracing and podcast icon

Inherited Arrhythmias and Genetic Cardiomyopathies: Evaluation and Management Essentials (Podcast)

Experts discuss advances in precision medicine, the value of collaborative care and more

colorful imaging model of a heart valve procedure

Cleveland Clinic Partners With DASI Simulations to Advance AI Guidance in TAVR

Collaboration includes clinical validation of predictive modeling tool, development of second-generation tool

Ad